Morgan Stanley Starts Prime Medicine (PRME) at Equalweight
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Price: $4.80 +0.42%
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
8 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison initiates coverage on Prime Medicine (NASDAQ: PRME) with a Equalweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Prime Medicine click here. For more ratings news on Prime Medicine click here.
Shares of Prime Medicine closed at $21.12 yesterday.
You May Also Be Interested In
- Chardan Capital Markets Assumes Prime Medicine (PRME) at Buy
- JPMorgan Starts COSCO SHIPPING Energy Transportation (600026:CH) at Neutral
- HSBC Starts Auna SA (AUNA) at Buy, 'Just what the doctor prescribed'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
